Bml Capital Management, LLC Pmv Pharmaceuticals, Inc. Transaction History
Bml Capital Management, LLC
- $124 Billion
- Q1 2025
A detailed history of Bml Capital Management, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 3,747,612 shares of PMVP stock, worth $3.52 Million. This represents 3.31% of its overall portfolio holdings.
Number of Shares
3,747,612
Previous 3,466,684
8.1%
Holding current value
$3.52 Million
Previous $5.23 Billion
21.96%
% of portfolio
3.31%
Previous 3.25%
Shares
5 transactions
Others Institutions Holding PMVP
# of Institutions
73Shares Held
41.7MCall Options Held
500Put Options Held
500-
Orbimed Advisors LLC San Diego, CA6.48MShares$6.09 Million0.26% of portfolio
-
Sio Capital Management, LLC New York, NY3.57MShares$3.36 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$3.3 Million0.08% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$2.47 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$2.2 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $42.9M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...